PMID- 19883619 OWN - NLM STAT- MEDLINE DCOM- 20100615 LR - 20211020 IS - 1932-7420 (Electronic) IS - 1550-4131 (Print) IS - 1550-4131 (Linking) VI - 10 IP - 5 DP - 2009 Nov TI - Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice. PG - 419-29 LID - 10.1016/j.cmet.2009.09.006 [doi] AB - Chronic low-grade inflammation, particularly in adipose tissue, is an important modulator of obesity-induced insulin resistance. The Toll-like receptor 4 (Tlr4) is a key initiator of inflammatory responses in macrophages. We performed bone marrow transplantation (BMT) of Tlr4lps-del or control C57Bl/10J donor cells into irradiated wild-type C57Bl6 recipient mice to generate hematopoietic cell-specific Tlr4 deletion mutant (BMT-Tlr4(-/-)) and control (BMT-WT) mice. After 16 weeks of a high-fat diet (HFD), BMT-WT mice developed obesity, hyperinsulinemia, glucose intolerance, and insulin resistance. In contrast, BMT-Tlr4(-/-) mice became obese but did not develop fasting hyperinsulinemia and had improved hepatic and adipose insulin sensitivity during euglycemic clamp studies, compared to HFD BMT-WT controls. HFD BMT-Tlr4(-/-) mice also showed markedly reduced adipose tissue inflammatory markers and macrophage content. In summary, our results indicate that Tlr4 signaling in hematopoietic-derived cells is important for the development of hepatic and adipose tissue insulin resistance in obese mice. FAU - Saberi, Maziyar AU - Saberi M AD - Department of Medicine, Division of Endocrinology and Metabolism, University of California, San Diego, La Jolla, CA 92093, USA. FAU - Woods, Niels-Bjarne AU - Woods NB FAU - de Luca, Carl AU - de Luca C FAU - Schenk, Simon AU - Schenk S FAU - Lu, Juu Chin AU - Lu JC FAU - Bandyopadhyay, Gautam AU - Bandyopadhyay G FAU - Verma, Inder M AU - Verma IM FAU - Olefsky, Jerrold M AU - Olefsky JM LA - eng GR - P01 DK074868-020001/DK/NIDDK NIH HHS/United States GR - DK033651/DK/NIDDK NIH HHS/United States GR - P01 DK074868/DK/NIDDK NIH HHS/United States GR - T32 DK007494-26S1/DK/NIDDK NIH HHS/United States GR - R37 DK033651-27/DK/NIDDK NIH HHS/United States GR - R01 DK033651/DK/NIDDK NIH HHS/United States GR - P30 DK063491/DK/NIDDK NIH HHS/United States GR - U54 HD 012303-25/HD/NICHD NIH HHS/United States GR - T32 DK007494/DK/NIDDK NIH HHS/United States GR - DK074868/DK/NIDDK NIH HHS/United States GR - P50 HD012303/HD/NICHD NIH HHS/United States GR - DK-063491-06/DK/NIDDK NIH HHS/United States GR - U54 HD012303-296875/HD/NICHD NIH HHS/United States GR - U54 HD012303/HD/NICHD NIH HHS/United States GR - R37 DK033651/DK/NIDDK NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PL - United States TA - Cell Metab JT - Cell metabolism JID - 101233170 RN - 0 (Dietary Fats) RN - 0 (Toll-Like Receptor 4) SB - IM MH - Adipose Tissue/*metabolism/pathology MH - Animals MH - Dietary Fats/administration & dosage MH - Gene Knockout Techniques MH - Glucose Clamp Technique MH - Glucose Intolerance/genetics/metabolism MH - Hematopoietic Stem Cells/*metabolism MH - Insulin Resistance/*physiology MH - Liver/*metabolism MH - Macrophages/metabolism MH - Mice MH - Mice, Obese MH - Obesity/etiology/*metabolism/pathology MH - Organ Specificity MH - Signal Transduction/physiology MH - Toll-Like Receptor 4/*antagonists & inhibitors/genetics/*metabolism PMC - PMC2790319 MID - NIHMS159434 EDAT- 2009/11/04 06:00 MHDA- 2010/06/16 06:00 PMCR- 2010/11/01 CRDT- 2009/11/04 06:00 PHST- 2008/10/26 00:00 [received] PHST- 2009/05/29 00:00 [revised] PHST- 2009/09/25 00:00 [accepted] PHST- 2009/11/04 06:00 [entrez] PHST- 2009/11/04 06:00 [pubmed] PHST- 2010/06/16 06:00 [medline] PHST- 2010/11/01 00:00 [pmc-release] AID - S1550-4131(09)00294-0 [pii] AID - 10.1016/j.cmet.2009.09.006 [doi] PST - ppublish SO - Cell Metab. 2009 Nov;10(5):419-29. doi: 10.1016/j.cmet.2009.09.006.